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Abstract
Transcription control at a distance is a critical mechanism, particularly for contiguous genes. The peptidylarginine
deiminases (PADs) catalyse the conversion of protein-bound arginine into citrulline (deimination), a critical reaction in the
pathophysiology of multiple sclerosis, Alzheimer’s disease and rheumatoid arthritis, and in the metabolism of the major
epidermal barrier protein filaggrin, a strong predisposing factor for atopic dermatitis. PADs are encoded by 5 clustered PADI
genes (1p35-6). Unclear are the mechanisms controlling the expression of the gene PADI3 encoding the PAD3 isoform, a
strong candidate for the deimination of filaggrin in the terminally differentiating epidermal keratinocyte. We describe the
first PAD Intergenic Enhancer (PIE), an evolutionary conserved non coding segment located 86-kb from the PADI3 promoter.
PIE is a strong enhancer of the PADI3 promoter in Ca2+-differentiated epidermal keratinocytes, and requires bound AP-1
factors, namely c-Jun and c-Fos. As compared to proliferative keratinocytes, calcium stimulation specifically associates with
increased local DNase I hypersensitivity around PIE, and increased physical proximity of PIE and PADI3 as assessed by
Chromosome Conformation Capture. The specific AP-1 inhibitor nordihydroguaiaretic acid suppresses the calcium-induced
increase of PADI3 mRNA levels in keratinocytes. Our findings pave the way to the exploration of deimination control during
tumorigenesis and wound healing, two conditions for which AP-1 factors are critical, and disclose that long-range
transcription control has a role in the regulation of the gene PADI3. Since invalidation of distant regulators causes a variety
of human diseases, PIE results to be a plausible candidate in association studies on deimination-related disorders or atopic
disease.
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Introduction
The characterization of the genomic elements which govern the
spatial and temporal tuning of gene transcription is a key issue in
genomic biology, providing with a better understanding of the cell
regulatory networks and the functional landscape of the genome
[1]. Notably, transcription control at a distance is a critical
mechanism, providing with cell-type specificity of transcription or
coordinate expression of clustered genes [2]. The 5 genes (PADI)
for the peptidylarginine deiminases (PADs) are clustered on
chromosome 1p35-36 (Genbank AJ549502) [3]. PADs catalyse
the conversion of protein-bound arginine into citrulline (deimina-
tion). Deimination associates with or is a signal for apoptosis [4],
and antagonizes histone arginine methylation contributing to
transcription control [5,6]. More, PADs are though to be key
factors in the pathophysiology of multiple sclerosis, Alzheimer’s
disease, and rheumatoid arthritis [7], and in the metabolism of the
major epidermal barrier protein filaggrin. Filaggrin (Unigene
Hs.654510) is only expressed in the most differentiated keratino-
cytes of the epidermis within the so-called granular layer. Filaggrin
associates with keratin intermediate filaments and facilitates the
formation of the intracellular fibrous matrix during the transition
from keratinocytes to corneocytes, which constitutes the cornified
layer of the epidermis. Filaggrin is extensively deiminated at
multiple residues in the early corneocyte [8]. Because of the lower
affinity of deiminated filaggrin for keratins, it was proposed that
filaggrin deimination facilitates its dissociation from the matrix and
subsequent proteolysis [8]. Proteolysis of the deiminated filaggrin
yields to a heterogeneous pool of aminoacids which contributes to
the Natural Moisturizing Factor (NMF) [9]. The critical role of
filaggrin in epidermis homeostasis and barrier function has been
evidenced by the recent disclosure that loss-of-function mutations
in the filaggrin gene underlie ichthyosis vulgaris (OMIM
#146700) and are strong predisposing factors for atopic dermatitis
(OMIM %603165)[10]. Abnormal filaggrin deimination should
result in altered function and/or turn-over; with possible
deleterious consequences in epidermis barrier function which
might contribute to the outcome of atopy or other disorders.
PAD3 is a strong candidate for filaggrin deimination. Among the
PADI genes, only PADI3 shows specific expression in the granular
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keratinocytes and in the matrix of the lower corneocytes [11]. The
enzymatic properties of PAD3 and its ability to deiminate filaggrin
in vitro [12] further support the assumption that PAD3 is the best
candidate for filaggrin deimination in vivo. In the search for new
regulators of filaggrin deimination, we investigated the control of
the genes PADI. We have reported that the PADI3 minimal
promoter region showed a significant, albeit moderate, increase in
activity (1.5-fold) in differentiated versus proliferative keratinocytes
in vitro, and required the bound transcription factors NF-Y and
Sp1/3 [13]. However, such co-operation is not specific to
differentiated keratinocytes since NF-Y and Sp1 govern the
transcription of a variety of genes in epithelial or non epithelial
cells [14–17], as that of the DNp63 isoform of p63, a homolog of
the p53 tumour suppressor gene, in proliferative mouse keratino-
cytes [18]. In the cervical carcinoma HeLa cells, NF-Y and Sp1
enhanced the levels of transcription of the topoisomerase II a and
b gene promoters [19,20] whereas the PADI3 gene promoter is not
active [13].
By a comparative genomic approach, we have identified
between PADI2 and PADI1 an 8-kb region (IG1) which clusters
19 conserved non coding segments (CNS) [3]. We here disclose
that IG1 contains a calcium responsive enhancer which dramat-
ically triggers the activity of the PADI3 gene promoter located 86-
kb from it upon epidermal keratinocyte differentiation, and links




All human samples were obtained after informed consent
according to Helsinki principles. Normal Human Epidermal
Keratinocytes (NHEKs) isolated from healthy foreskin and the
A431 and HaCaT lines (a gift from N. Fusenig, German Cancer
Research Center, Heidelberg, Germany) were cultured in a
serum-free growth medium (KGM2, Promocell, Heidelberg,
Germany) in the presence of 13 mg/ml bovine pituitary extract,
0.125 ng/ml Epidermal Growth Factor, 5 mg/ml insulin,
0.33 mg/ml hydrocortisone, 10 mg/ml transferrin, 0.39 mg/ml
epinephrin, and with either 0.2 mM or 1.5 mM Ca2+. Human
dermal fibroblasts and HeLa cells were maintained in DMEM
with 10% (v/v) fetal bovine serum (Invitrogen, Carlsbad, CA).
Genomic segments and plasmids
All sequences coordinates refer to a previously deposited
sequence (Genbank accession number AJ549502). The primers
used in this work are listed in supplementary Table S1. The
promoter regions of the genes PADI1-4 comprise the proximal
promoters published elsewhere [13,21–23]. Genomic fragments
were generated by PCR and subcloned into the pGL3 vector
(Promega, Madison, WI). Site-directed mutagenesis was per-
formed using the Vent DNA polymerase and DpnI (New England
Biolabs, Ipswich, MA). All constructs were checked by sequence
analysis. Dominant-negative plasmids were generous gifts from
Melanie Cobb (ERK1-2 mutants), Michael Karin (h-ras, h-raf
constructs), and Michael Birrer (TAM67 c-Jun mutant). The
plasmid pAP1-luc (BD Bioscience, Mountain View, CA) was
kindly provided by Franck Verrechia.
Transient transfections and luciferase assays
Actively proliferating NHEKs were seeded at a density of
25 000 cells/cm
2 24 hours before they were transfected by 1 mg
total DNA using the TransFast reagent (Promega). The plasmid
pCR2.1 (Invitrogen) was used to adjust for the mass of the input
DNA when necessary. The plasmid pRL-TK (Promega), used to
correct for transfection efficiency, was used at a 1/100 mass ratio
versus the pGL3 plasmids. After transfection, the NHEKs were
incubated 72 hours in the presence of either 0.2 mM or 1.5 mM
calcium before lysis and dual luciferase assay (Promega). All assays
were done in triplicate wells, and the experiments were repeated at
least two times. Statistical analysis was performed using the StatEL
software (Adscience, Paris, France).
Real time quantitative (Q-)PCR analysis
All Q-PCRs were based on a SyBr-green based PCR mixture
(MP Biomedicals, Solon, OH) and an ABI7300 system (Applied
Biosystems, Foster City, CA). All primers pairs were designed
using the Primer3 online software (http://frodo.wi.mit.edu/) and
characterized by real-time amplification of a series of dilution of
naked genomic DNA to determine linearity range and primer
efficiency. All Q-PCR amplifications were done in triplicate, and
the experiments were performed at least twice.
DNase I hypersensitivity assay
We queried the DNase I hypersensitivity of genomic segments
as devised elsewhere [24], using oligonucleotides probes listed in
supplementary Table S1.
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear proteins were extracted as devised elsewhere [25], and
protein amounts were quantified using a Bradford assay (Amresco,
Solon, OH). EMSA was performed as reported elsewhere [26].
Briefly, 5 mg of whole cell extract from differentiating NHEKs was
incubated in a binding buffer containing 10 mM Hepes, pH 7.8,
50 mM KCl, 2 mM dithiothreitol, 1 mM EDTA, 5 mM MgCl2,
10% glycerol, 3 mM 4-(2-aminoethyl)benzenesulfonyl fluoride,
2 mg/ml poly(dI-dC), and 2 mg/ml bovine serum albumin in a
total volume of 20 mla t2 5uC for 20 min in the presence of
20 fmol of biotin-end-labeled double-strand oligonucleotide
probe. DNA-protein complexes were resolved by electrophoresis
on 4–6% polyacrylamide gels in 0.56TBE buffer (50 mM Tris,
45 mM Boric Acid, and 0.5 mM EDTA). Five or 10 mg of antisera
against c-Jun (BD, Franklin Lakes, NJ), JunB, JunD, c-Fos, FosB,
Fra1 and Fra2 (Santa Cruz Biotechnologies, Santa Cruz, CA) were
used in supershift assays. Nucleoprotein complexes were revealed
by the Light Shift chemoluminescent assay kit (Pierce, Rockford,
IL). Oligonucleotide probes were designed on the basis of the
sequence of the centromeric and telomeric AP-1 sites of PIE.
Competitors were unlabelled oligonucleotides with the identical
sequence (wild-type competitor), or unlabelled oligonucleotides in
which the AP-1 consensus sites were mutated (mutated compet-
itor). All probe and competitor sequences are detailed in
supplementary Table S1.
Chromatin ImmunoPrecipitation (ChIP) assay
ChIP was carried out as published elsewhere [27] using 20610
6
NHEKs per experiment. Twenty-five mg of pre-cleared chromatin
were immunoprecipitated with 5 mg of the same antibodies that
described above, or 5 mg of a monoclonal antibody against the HA
epitope (Millipore, Billerica, MA). One tenth of the immunopre-
cipitated DNA samples and 5 ng input DNA samples were
submitted to Q-PCR.
Chromosome Conformation Capture (3C)
Detailed protocol for 3C in NHEKs is provided as Supplemen-
tary Information S1.
Long Range Control of PADI3
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using BglII and BamHI for enzymatic digestion of chromatin, and
primers designed towards the BamHI restriction sites. A sonication
step was found to be necessary after formaldehyde cross-linking of
NHEKs for efficient cell lysis and nuclei release, as verified by
microscopic examination, but had no detectable effect on
chromatin size, as checked by agarose gel electrophoresis. Agarose
gel electrophoresis of a purified aliquot of the chromatin restricted
by BglII and BamHI showed no detectable difference in digestion
efficiency of samples from unstimulated or calcium-stimulated
keratinocytes. Quantitative amplification of a segment of the
PADI3 gene promoter was used for data normalization. For
controls, we used the Bacterial Artificial Chromosome (BAC,
AL590644) which contains a 165-kb insert spanning the whole
region from the intergenic sequence telomeric to the gene PADI2
to the first intron of the gene PADI4, thereby including IG1 and
the genes PADI1 and 3. The BAC clone was used to generate the
control for random association events: 1.5 ng of the BAC
preparation, restricted and ligated as the nuclei samples, was used
as a template in control amplifications. Primer pairs efficiency
values were determined from amplifications of a series of dilutions
of a control template in which all possible BamHI/BglII ligation
products of the PADI gene locus should be equally represented,
generated from 30 mg of the BAC preparation, restricted and
ligated at a high concentration (300 ng/ml).
RNA analysis
NHEKs were treated for 16 h by 20 mM NDGA (Sigma) in
0.1% DMSO (Sigma), or by 0.1% DMSO. Total RNAs purified
using the RNeasy Protect kit (Qiagen) were used as a template for
Im-PromII reverse transcriptase (Promega). Q-PCR analysis was
performed according to the 2
2DCt method [29], using b2
microglobulin as the reference, PAD1-3 and involucrin as the
targets, and untreated NHEKs as the calibrator. Standard
deviation were calculated as advised [29] using the methods of
standard propagation of error. Actual inhibition of the AP-1
activation system by NDGA was also checked by transfection
experiments using the plasmid pAP1-luc.
Results
Normal human epidermal keratinocytes (NHEKs) grown in vitro
in the presence of 0.2 mM calcium are actively proliferating.
Upon exposure to 1.5 mM calcium, they undergo a differentiation
program which closely resembles that of the epidermis; this well
documented system recapitulates the natural epidermal calcium
gradient [30,31]. Consistently, in our hands, quantitative RT-PCR
and/or western blot analyses show increased mRNA and/or
protein levels of markers of the keratinocyte differentiation such as
loricrin, involucrin, and the a-macroglobulin like inhibitor of
protease A2ML1 (not shown, and [32]). The 19 CNS within IG1
are candidates for a role in transcription regulation because inter-
species conservation of DNA segments is often predictive of a
biological role. We designed a screening strategy based on
transfection in NHEKs cultured in both conditions of luciferase
reporter plasmids containing the promoter region of the gene
PADI3, flanked by each of the 19 CNS. We observed a
significantly increased activity of the PADI3 promoter region in
the presence of the CNS2 (63 bp, nt 109097–109159). The effect
was higher in calcium-stimulated (10-fold induction) as compared
to unstimulated cells (6-fold induction) (Fig. 1A). None of the 18
other CNS showed significant and reproductible effect upon the
PADI3 gene promoter activity. The activity of the CNS2 did not
depend on its orientation (data not shown). This activity was not
donor dependent, since it was observed in NHEKs from 4
unrelated individuals. We observed a moderate enhancer effect on
the PADI2 gene and the SV40 virus promoter regions in the
presence of 1.5 mM calcium. We next queried wether such
enhancer activity could be detected in keratinocyte lines.
Unexpectedly, the activity of the CNS2 could not be detected in
HaCaT immortalized keratinocyte though they are able to
differentiate in vitro upon calcium exposure (Fig. 1B). We assume
that the genetic alterations present in the HaCaT lineage (one
single copy of chromosome 3p, 4p, and 9p and an additional copy
of 9q at least) impair the cell responsiveness to CNS2 directly or
not. However, the underlying mechanism remains undetermined,
given the complexity of genetic alterations and accumulating
changes upon passaging in such immortalized cells.
No effect of CNS2 was observed in skin squamous cell
carcinoma keratinocytes A431 and cervix adenocarcinoma HeLa
cells which are unable to differentiate in vitro (Fig. 1B). Neither was
it detected in primary human dermal fibroblasts (Fig. 1B), nor 3T3
transformed murine fibroblasts (not shown). These results
suggested sensitivity to cell type and status.
Because active enhancers are known to be located in open
chromatin regions and thereby show DNase I hypersensitivity, we
used a real-time PCR-based approach to assess the integrity of the
CNS2 in DNase I treated nuclei prepared from NHEKs [24]. This
method had been reported efficient to query the nuclease
sensitivity of candidate segments [33,34] or to build comprehen-
sive maps of open chromatin sites at the genomic or chromosomic
levels [35,36]. We normalized the number of intact remaining
copies of CNS2 or of other probes to that of a segment of the
promoter region of the fetal e-globin gene (HBE1) which is not
transcribed in NHEKs. No significant DNase I hypersensitivity of
the CNS2 was detected in proliferating NHEKs, in which a
fragment spanning the promoter of the keratin 5 gene, a strongly
expressed marker of proliferative keratinocytes, showed hypersen-
sitivity (Fig. 2). In contrast, in calcium-stimulated keratinocytes,
increasing amounts of DNase I associated with a dramatic loss of
amplifiable copies of the CNS2 (Fig. 2), supporting its role as an
enhancer prone to bind transcription activators upon keratinocyte
differentiation. Two segments located at the centromeric ends of
IG1 showed no hypersensitivity to DNase I (Fig. 2), suggesting that
the increased sensitivity to DNAse I we observed was due to local
alteration in chromatin accessibility in the close or distant vicinity
of the CNS2, and not to a chromatin opening event at the
chromosome scale. We concluded that the CNS2 overlaps a strong
calcium-dependent enhancer of the PADI3 gene in NHEKs.
Therefore we renamed it Peptidylarginine deiminase Intergenic
Enhancer (PIE, EU443247 and AJ549502).
BLAST searches in the most recently available mammalian and
nonmammalian draft genomes of the Ensembl database and the
trace archives of the National Center for Biotechnology Informa-
tion (NCBI), followed by sequence analysis identified one highly
conserved canonical AP-1 binding sequence at each ends of PIE
(Fig. 3 A). Invalidation of one or another or both AP-1 sites by site-
directed mutagenesis resulted in the almost complete loss of PIE
enhancer activity in luciferase assays (Fig. 3 B, lanes 1–3).
Similarly, deletion of one or another or both AP-1 sites within the
reporter plasmids resulted in the loss of PIE activity (not shown). In
the epidermis, the AP-1 family groups heterodimeric proteins
consisting of members of the Jun (c-Jun, JunB, JunD), or Fos (c-
Fos, FosB, Fra1, Fra2) families, or Jun homodimers. Electropho-
retic mobility shift assays (EMSA) with or without antibodies
specific to each member of the Jun/Fos families was performed
using nuclear extracts from differentiating NHEKs to assess
wether the binding of AP-1 factors could account for the observed
Long Range Control of PADI3
PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3408Figure 1. Identification of a strong transcriptional enhancer of the gene PADI3 in differentiated keratinocytes. A) The CNS2 comprises
an enhancer of PADI3 gene promoter activity in differentiating NHEKs. NHEKs were transfected with luciferase reporter constructs containing the
indicated promoter segment with or without the CNS2 which overlaps PIE, in the presence of 0.2 or 1.5 mM calcium. Values are expressed in Relative
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JunB were expressed and able to bind the two AP-1 sites within
PIE in differentiating keratinocytes (Fig. 3 C). Chromatin
immunoprecipitation (ChIP) assays revealed a significantly in-
creased occupancy of PIE by c-Jun and c-Fos in stimulated versus
unstimulated NHEKs (2.9 and 2.8 -fold, respectively) (Fig. 3 D,
grey boxes). No significant increase in occupancy by c-Jun and c-
Fos was found when we queried a non related, non coding
segment within IG1 (CNS3) (Fig. 3D, white boxes). Last, the effect
of PIE on the PADI3 gene promoter was found impaired in
stimulated NHEKs co-transfected with the c-Jun dominant
negative mutant TAM67 [37] (Fig. 3 E). We concluded that c-
Jun and c-Fos are recruited at PIE and that c-Jun at least is
mandatory for the enhancer activity of PIE in differentiating
NHEKs. This is consistent with c-Jun and c-Fos being detected in
the epidermal granular layer, c-Jun being specific of this later in
most reports [38,39]. Since the basal activity of the PADI3 core
promoter required binding of the factors Sp1/3 and NF-Y [13],
we mutated the CCAAT or the GC-boxes, which bind NF-Y and
Sp1/3 respectively, within the PADI3 promoter sequences in
reporter plasmids. When inserted upstream the promoter
sequence with any of the CCAAT boxes invalidated, PIE no
longer showed any effect on luciferase activity. In contrast,
mutations invalidating the GC boxes did not impair PIE enhancer
effect (Fig. 3 B, lanes 4–7). These results suggested functional
interaction of PIE with the CAAT boxes, presumably through c-
Jun interacting with NF-Y as shown for the p21(WAF1/Cip1)
gene [40]. We failed to detect by ChIP significant amounts of c-
Jun at the promoter level (not shown). We assume this was due to
the limits of ChIP when applied to proteins associated with
chromatin without being directly bound to the DNA helix [41].
AP-1 activity has been shown to be induced by the
Extracellular-Regulated Kinase (ERK) signalling pathway upon
keratinocyte differentiation [42]. Cotransfections of NHEKs with
the PIE-PADI3 promoter reporter plasmid and any of the
dominant negative mutants of ras, raf, ERK-1 or -2 all resulted
in a dramatically decreased gain of the PADI3 gene promoter
activity (Fig. 3 E), indicating that PIE is a downstream effector of
AP-1 through the ras/raf/ERK cascade. The expression of the
dominant negative mutants associated with the loss of AP-1
activity, as controlled by parallel co-transfection experiments using
the plasmid pAP1-luc designed for direct monitoring of the activity
of the AP-1 activation pathway (Fig. 3 E).
Recent evidence showed close proximity between long-range
enhancers and promoters through chromatin loops [43]. We
searched for non-random alterations in the frequency of contacts
between the PADI3 gene promoter and PIE in living keratinocytes
by the use of Chromosome Conformation Capture (3C, Fig. 4)
[44]. Controls were included as advised elsewhere [45] (see
methods). Chimeric DNA containing PIE and the PADI1o r
PADI3 promoter regions were amplified using the oligonucleotide
pairs BB02L/BP1R and BB02L/BP3R, respectively (Fig. 4, top).
3C allowed detection of chimeric DNA containing PIE and the
PADI3 promoter region, generated by self-ligation of physically
close fragments from crosslinked and restricted chromatin. More,
the abundancy of such PIE-PADI3 chimeric DNA was found to be
more than 20-fold greater in stimulated keratinocytes than that in
unstimulated keratinocytes or dermal fibroblasts (Fig. 4, bottom), a
magnitude greater than that reported for the b globin chromatin
hub [28,46]. In contrast, the ratio between the abundancy of PIE-
PADI1 chimeric DNA in unstimulated versus stimulated NHEKs
was found 9-fold lower than that corresponding to PIE and PADI3
promoter, and not sensitive to calcium-stimulation (Fig. 4). No
chimeric DNA could be amplified from the BAC-based control for
random association events (Fig. 4), or from crude genomic DNA
(not shown). This indicated non random physical association
between PIE and the PADI3 gene promoter in the nuclei of
differentiating NHEKs, through a chromatin looping spanning 86-
kb.
We next queried whether the inhibition of the AP-1 pathway
could have an effect upon the PADI3 mRNA levels in
differentiating NHEKs (Fig. 5). We used nordihydroguaiaretic
acid (NDGA), a natural polyphenolic compound reported to
inhibit c-fos mRNA and protein levels, as well as binding of the
fos-jun dimer to DNA in keratinocytes [47,48] and in vitro assays
[49]. It also inhibits the auto-regulated synthesis of c-jun mRNA in
TPA-stimulated HL60 cells [50]. Consistently, transfection of
pAP1-luc yielded no significant luciferase activity in keratinocytes
treated with NDGA, in contrast to keratinocytes untreated or
treated by the carrier (0.1% DMSO) (not shown). We performed
real-time RT-PCR to investigate the levels of mRNA in calcium
stimulated or unstimulated keratinocytes, treated or not with
NDGA. For unknown reasons, 0.1% DMSO resulted in an
Luciferase Units (RLU), as means+/2SEM for at least 3 independent experiments, each performed in triplicate wells.*, p,0.05. B) The CNS2 does not
show any detectable enhancer activity either in A431 skin squamous cell carcinoma keratinocytes (top left), in HeLa cervix adenocarcinoma cells (top
right), in immortalized HaCaT (bottom left) keratinocytes, or in human primary dermal fibroblasts (bottom right), or 3T3 transformed murine
fibroblasts (not shown). C) Schematic representation of the PADI gene locus showing CNS2/PIE (asterisk), IG1 (open box) and the genes PADI1-3
(open boxes with arrows indicating the orientation of transcription). The coordinates in AJ549502 are shown in kb or bp. The telomeric (tel) and
centromeric (cen) ends of the locus are shown. The 19 CNSs within IG1 are depicted by vertical bars of lenght depending upon their level of
interspecies conservation (for details, see [3]). The entire mouse and human sequences of CNS2/PIE are shown. Underlined are the conserved bases
between mouse and human. The centromeric end of the locus (approximatively 100 kb) including the genes PADI4 and 6 is not shown due to size
limitation.
doi:10.1371/journal.pone.0003408.g001
Figure 2. Hypersensitivity of the CNS2 to DNase I. The DNase I-
digestion profiles of the CNS2 including PIE, the KRT5 gene promoter
region, and the two segments 114k (a LINE repeat, nt 114-549-114655)
and 115k (nt 115764–115778) located at the centromeric end of IG1 are
shown. The amount of template DNA was standardized by correcting
for amplification of the HBE1 promoter region sequence. Inset:
representative dissociation curves.
doi:10.1371/journal.pone.0003408.g002
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PLoS ONE | www.plosone.org 5 October 2008 | Volume 3 | Issue 10 | e3408Figure 3. AP-1 factors binding and proximal CAAT motifs required for enhancer activity. A) Two conserved AP-1 sites were identified in
PIE. Alignment of the sequences of the conserved telomeric or centromeric AP-1 putative binding sites (bold) in PIE in human, mouse, rat, dog, cow,
armadillo (Dasypus novemcinctus), hedgehog (Echinops telfairi) and platypus (Ornithorhynchus anatinus). Sequence retrieval and analyses were
performed using the Ensembl web site (http://www.ensembl.org), the Vista suite (http://genome.lbl.gov/vista/index.shtml), and the program Dialign-
TF (http://www.genomatix.de) with default parameters. Note that the centromeric site is more highly conserved that the telomeric site. B) AP-1 and
CAAT recognition motifs are mandatory for enhancer activity. Luciferase (luc) plasmids were engineered with invalidated telomeric (AP-1t) and
centromeric (AP-1c) AP-1 sites in PIE (lines 1–3), or invalidated CCAAT or GC boxes in the PADI3 promoter (cross) (lines 4–7). Line pC2-PADI3-luc:
shown is the ratio between the luciferase activity of the PADI3 promoter segment with PIE versus that without PIE. Lines 1–3: shown are the ratios
between the luciferase activities of the mutated constructs versus that of the construct containing the PADI3 promoter segment without PIE. Lines 4–
7: shown are the ratios between the luciferase activities of the mutated constructs with PIE versus that of their counterparts without PIE. Values are
Long Range Control of PADI3
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NHEKs, but had no effect in stimulated NHEKs (Fig. 5A).
Whatsoever, treatment with NDGA resulted in a dramatic
decrease of PADI3 mRNA levels in stimulated NHEKs, to a level
close to that observed in untreated unstimulated NHEKs (Fig. 5A).
We found no sensitivity to NDGA treatment of the PADI1o r
PADI2 mRNA levels in calcium-stimulated NHEKs (Fig. 5A). We
next queried the effect of NDGA upon the mRNA levels of a well-
established AP-1 target gene, the early marker of keratinocyte
differentiation involucrin [51](UniGene Hs.516439) (Fig. 5B). In
expressed as means+/2SEM for 2 independent experiments, each performed in triplicate wells. C, D) Bound c-Fos/c-Jun are required for PIE function.
Electrophoretic mobility shift assays (C) showed that both telomeric (AP-1t) and centromeric (AP-1c) AP-1 sites are expressed and able to bind nuclear
factors from differentiating NHEKs, generating a shifted band, which is no longer detected in the presence of unlabeled wild type competitor. When
antibodies specific to c-Jun, JunB or c-Fos were used, the shifted band was either supershifted or absent due to the formation of antibody-containing
higher molecular weight complexes which do not enter the gel. The binding of c-Jun and c-Fos to PIE in living NHEKs was confirmed by chromatin
immunoprecipitation (D). Immunoprecipitated chromatin from NHEKs grown in the presence of 1.5 mM calcium showed about 3-fold relative
enrichment in c-Jun or c-Fos bound to PIE as compared to that from NHEKs grown in the presence of 0.2 mM calcium (grey bars). No enrichment was
observed using antibodies to JunB or the irrelevant anti-hemaglutinin (HA), nor when we queried the unrelated CNS3 which is centromeric to the
CNS2 (nt 109913–109973) (white bars). Data are shown as means+/2SEM for 2 independent experiments performed in triplicate wells. E) Blocking c-
Jun or the ras/raf/ERK cascade impairs the activity of PIE. Differentiating NHEKs were co-transfected with reporter plasmids containing the PADI3 gene
minimal promoter region fitted or not with PIE, and an expression vector coding for dominant negative mutants of c-Jun (TAM67), ras (ras-), raf (raf-),
ERK1 and 2 (ERK1- and ERK2-, respectively) or the GFP as a control (GFP) (top). For these co-transfections, the luciferase activities generated by the
plasmids containing PIE were compared with that generated by the plasmids containing only the PADI3 gene promoter. Parallel co-transfection
experiments using the plasmid pAP1-luc showed dramatic loss of AP-1 activity in NHEK transfected with the dominant negative mutants (bottom).
For these co-transfections, the luciferase activities generated by pAP1-luc co-tranfected with mutants were compared with that generated by pAP1-
luc transfected alone. The plasmid pCR2.1 was used to adjust for the mass of the input DNA. Values are expressed as means+/2SEM for 2
independent experiments performed in triplicate wells.
doi:10.1371/journal.pone.0003408.g003
Figure 4. Increased frequency of interaction between PIE and the PADI3 promoter indicating chromatin looping. The abundancy of
chimeric DNA containing PIE and the promoter region of the genes PADI1o rPADI3 were explored by 3C analysis using specific primers (top). The
levels of PIE-PADI3 promoter chimeric DNA in extracts from NHEKs grown in the presence of 1.5 mM calcium were approximately 20-fold greater than
that in NHEKs grown in the presence of 0.2 mM calcium, or dermal fibroblasts. Amplification of BAC-based negative control for random association
events (see methods) yielded no product (not shown). All amplifications were performed in triplicate wells. Results were normalized with respect to
the abundancy of the PADI3 promoter sequence in the template. Data are expressed in Relative Units (RU) as means+/2SEM for 2 independent
experiments, each performed in triplicate wells.*, p,0.05. Representative dissociation curves (inset) show the major amplimer peaks (arrow) along
with secundary peaks (arrowhead) indicative of primer-dimer formation in some experiments. Such possible primer-dimer was not detectable in
ethidium-bromide stained agarose gel of the end-point PCR reactions and did not seem to interfere with calibration curves.
doi:10.1371/journal.pone.0003408.g004
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increase in involucrin mRNA levels. In NHEKs treated with the
carrier (DMSO), calcium stimulation associated with a five fold
increase in involucrin mRNA levels. In NHEKs treated with
NDGA, calcium stimulation associated with only a 1.5 fold
increase in involucrin mRNA levels. Together these results
suggested that treatment with NDGA blocked calcium-induced
increase of the PADI3 and involucrin mRNA levels and were
consistent with the assumption that targeting the AP-1 system by
NDGA has a negative effect upon PADI3 expression. We next
performed ChIP analysis to investigate the influence of NDGA
upon PIE occupancy by c-Jun/c-Fos (Fig. 5C). We compared the
number of copies of PIE present in fractions immunoprecipitated
with the c-Jun antiserum or the c-Fos antiserum or a blank rabbit
serum, from NHEKs grown in the presence of 0.2 mM or 1.5 mM
calcium with or without NDGA. Immunoprecipitated chromatin
from differentiating NHEKs grown in the presence of NDGA
revealed strongly decreased occupancy of PIE by c-Jun (20%
copies remaining) or c-Fos (34% copies remaining) as compared to
differentiating NHEKs grown in the presence of the carrier
(Fig. 5C). Immunoprecipitated chromatin from differentiating
NHEKs grown in the presence of NDGA showed a much lower
decrease in the non specific occupancy of PIE (74% remaining) as
compared to the same cells grown in the presence of the carrier
Figure 5. NDGA blocks calcium-induced increase of the PADI3 mRNA levels and impairs c-Jun or c-Fos recruitment at PIE.
Quantitative RT-PCR analysis of the steady-state levels of PADI1-3 (A) and involucrin (B) mRNAs was performed using unstimulated or calcium-
stimulated NHEKs grown in the presence of 20 mM NDGA in 0.1% DMSO, or 0.1% DMSO, and the b2-microglobulin mRNA as the reference. Data are
expressed as means+/2SEM for 2 independent experiments, each performed in triplicate wells.*, p,0.05. A) NDGA blocks calcium-induced increase
of the mRNA levels of PADI3, but not that of PADI 1, 2. Treatment with 0.1% DMSO had no effect on the PADI3 mRNA levels (2
(2DDCt)) in calcium-
stimulated NHEKs. Treatment with 20 mM NDGA resulted in a dramatic decrease of PADI3 mRNA levels in calcium-stimulated NHEKs. B) NDGA blocks
calcium-induced increase of the involucrin mRNA levels. In untreated NHEKs, calcium stimulation resulted in a two fold increase in involucrin mRNA
levels. In NHEKs treated with the carrier (DMSO), calcium stimulation associated with a five fold increase in involucrin mRNA levels. In NHEKs treated
with NDGA, calcium stimulation associated with only a 1.5 fold increase in involucrin mRNA levels. Together these results suggested that treatment
with NDGA blocked calcium-induced increase of the PADI3 and involucrin mRNA levels. RU, relative units. C) NDGA impairs c-Jun or c-Fos recruitment
at PIE in calcium-stimulated NHEKs. ChIP analysis of PIE occupancy by c-Jun/c-Fos was performed in the presence of NDGA or the carrier (DMSO).
Immunoprecipitated chromatin from NHEKs grown in the presence of 1.5 mM calcium showed strongly decreased occupancy of PIE by c-Jun (20%
remaining) or c-Fos (34% remaining) but not non specific factors (74% remaining) in the presence of NDGA as compared to the same cells grown in
the presence of the carrier. Immunoprecipitated chromatin from NHEKs grown in the presence of 0.2 mM calcium showed no decrease in the
occupancy of PIE by c-Jun (99% remaining) or c-Fos (130% remaining) or non specific factors (140% remaining) in the presence of NDGA as compared
to NHEKs grown in the presence of the carrier. Data are expressed as Relative Units (RU) and shown as means+/2SEM for 2 independent experiments
performed in triplicate wells. *, p,0.05.
doi:10.1371/journal.pone.0003408.g005
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the presence of 0.2 mM calcium showed no decrease in the
occupancy of PIE by c-Jun (99% remaining) or c-Fos (130%
remaining) or non specific factors (140% remaining) in the
presence of NDGA as compared to the same cells in the presence
of the carrier (Fig. 5C). These results strongly suggested that
NDGA treatment is associated with a dramatic decrease in c-Jun
or c-Fos recruitment at PIE. Altogether these findings supported
that proper AP-1 activation system and PIE occupancy by c-Jun or
c-Fos are necessary for calcium-dependent increase of the PADI3
mRNA levels.
Discussion
Our findings show that a distal enhancer located 86-kb
telomeric to the gene PADI3, namely PIE, underlies efficient
transcription of this gene in calcium differentiated epidermal
keratinocytes through binding to AP-1 factors and in association
with chromatin looping (Fig. 6). To our knowledge, PIE exhibits
all requirements for an enhancer: its sequence is highly conserved
in mammals, it exerts a strong effect on the PADI3 gene promoter
in vitro, and, in conditions when the gene PADI3 is specifically
upregulated, it is DNase I hypersensitive, shows non random
physical proximity to the PADI3 gene promoter, and binds
transcription activators (AP-1). We found that the AP-1 inhibitor
NDGA suppresses the calcium-induced increase of PADI3 mRNA
levels in keratinocytes, and the occupancy of PIE by c-Jun and c-
Fos. However, possible non-specific cellular effects of NDGA can
not be ruled out. Targeting experiments with silencing RNAs
specific to c-Jun and/or c-Fos would help to adress this issue.
We observed an effect of PIE upon the heterologous SV40
promoter, such as observed with a variety of other AP-1 bound
distal enhancers as those for the human renin gene promoter [52],
the mouse laminin a3A gene [26], or the sheep interferon t gene
[53]. It is likely due to the positive interaction between c-Jun and
the factor Sp1 which binds to the SV40 promoter, as observed in a
number of studies [54–56]. Direct interaction with the viral
TATA-box throught the TATA-box binding protein (TBP) is also
a possible mecanism, given the ability of c-Fos and c-Jun proteins
to interact directly with TBP [57].
Because PIE is located within the PADI1-2 intergenic region, it
supports the assumption that the use of distant cis-regulatory
elements contributes to maintain the physical organization of the
locus [3]. We retrieved ortholog PIE sequences from placental
mammals and monotreme (platypus) (Fig. 3A), but not from
nonmammalian vertebrates, what suggests that PIE is a mamma-
lian novelty. The role of the other CNS in IG1, should they have
any, is unknown. It is possible that they exert a function respective
to other PADI genes, cell types, or stimuli than the ones we
queried. We recently identified another calcium-responsive
enhancer activity lying within a large restriction fragment of IG1
(VA, unpublished data), presumably arising from the possible co-
operation between two or more CNS with no detectable activity
when assayed individually, or from a subsequence that had not
been listed as a CNS because of a lower degree of conservation.
AP-1 factors are key regulators of cell life and death through the
control of gene transcription in response to extracellular stimuli
such as growth factors or cytokines [58]. Specifically, c-Jun/c-Fos
heterodimers have been reported to be activators of the
transcription of the genes encoding profilaggrin [59], loricrin,
involucrin and transglutaminase 1 [60], all critical components of
the terminally differentiated keratinocyte. Also, our results pave
the way to the exploration of deimination control during
tumorigenesis and wound healing, two conditions for which AP-
1 factors are critical [61,62]. Our results reveal that the ras/raf/
ERK cascade is required for PIE activity during calcium-mediated
NHEK differentiation. However, AP-1 factors can also be
activated by the JNK/P38 kinase pathway upon stimulation by
pro-inflammatory cytokines or genotoxic stress [58], and AP-1
transactivation is a key downstream events that results from UVB
irradiation in keratinocytes [63]. Whether the JNK/P38 pathway
has a role on PIE activity remains to be addressed, and would be
of interest with respect to the molecular responses of epidermal
keratinocytes to genotoxic stress.
This is the first time distant regulation of a PADI gene is
reported. We observed local chromatin opening and chromatin
looping in conditions when PIE-bound AP-1 factors trigger
transcription of the gene PADI3. Though we can not rule out
that these events are simply correlative, together our findings
strongly support that the increased proximity between PIE and the
PADI3 gene promoter through chromatin bending is at least a
major contribution in PADI3 enhanced transcription. This is
consistent with the model that chromatin plasticity is a key feature
for genome expression [2,44]. Long-range enhancers have been
identified in a variety of chromosomal regions and tissues, at a
distance up to 1-Mb from their cognate promoters [2]. Chromatin
loops have been reported to play a role in the cell specificity of
Figure 6. Possible model for PADI3 promoter regulation. The binding of cJun and/or cFos dimers to the AP-1 sites of PIE is enhanced in
calcium-stimulated keratinocytes and increases the rate of transcription of PADI3 (broken arrow). Transcription factors with functional association
(cJun, cFos, NF-Y) are shown as open circles. Sp1/3 factors are denoted as grey circles. Transcription factors binding sites are indicated (capital letters).
The arrows show the transcription orientation of the genes PADI1-2 (white boxes). TBP: TATA-box binding protein; pol II: RNA polymerase II.
doi:10.1371/journal.pone.0003408.g006
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the activation of cooperative interactions [64]. PIE is located 86-kb
away from the PADI3 gene promoter on chromosome 1p36. It has
been proposed that the Wilms’ tumour suppressor gene, WT1, also
located on 1p35-36, is regulated by an enhancer away from more
than 9-kb of its 59 proximal region [65]. The identification of a
distant transcriptional enhancer of the gene SPRR1A within the 5-
Mb epidermal differentiation complex (EDC) on 1q21 was an
important finding to understand the control of its expression in
keratinocytes in vitro and in vivo [66]. More, the transcription of the
p63 gene is regulated by a keratinocyte-specific enhancer located
160-kb away on chromosome 3q28 [67]. Together with these
studies, our findings support that transcriptional regulation at a
distance might be a key issue in keratinocyte biology.
In conclusion, the genetic bases of the distinctive patterns of
expression of the genes PADI are unclear, despite the character-
ization of their respective core promoters. We assume that long
range control of transcription, involving IG1 or introns, should
have a role in the regulation of deimination. A forthcoming
transgenic mouse model will definitely elucidate the role of PIE in
vivo, in normal or pathological conditions. The impairment of long
range control underlies a variety of severe human disorders [2].
Therefore PIE and other CNS within IG1 can be reasonably
considered as candidates in association studies for deimination-
related disorders or atopic disease, and we have included them in a
recently initiated screen of the PADI locus in the search for variant
haplotypes possibly associated with rheumatoid arthritis.
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